Potential molecular therapy reverses placental development issues in mice

A signal that the body adds to an mRNA can disrupt placental development and lead to fetal growth restriction (FGR). In this condition, a fetus is smaller than expected for its age during pregnancy and complications such as feeding difficulties, jaundice, and stillbirth can result. A molecule called STM2457 reversed most of the effects in mice and could someday be used to treat patients, according to research published in The FASEB Journal.

Facebook Comments